FILTER

Refine your search with the following facets to narrow down your results.

6 Current news of Reinnervate

Reprocell acquires Reinnervate and BioServe

07-Aug-2014 - Reinnervate Ltd has been acquired by Reprocell of Shin-Yokohama in Japan. Reprocell, a pioneer in the field of induced pluripotent stem cell biology supplies iPSC-dervided Hepatocytes, Neurons and Cardiomyocytes as well as a range of media and reagents for stem cell culture. Reprocell intends to ...

acquisitions cell cultures induced pluripotent stem cells

Reinnervate and Oncotest enter collaboration agreement

11-Jan-2013 - Reinnervate Ltd announced that it has entered into a co-marketing agreement with the pre-clinical Oncology CRO Oncotest GmbH. Under the terms of the partnership, Oncotest will offer automated assays based on Alvetex®Scaffold technology, complementing their 3D Tumour Clonogenic Assay ...

Top award for 3D cell culture pioneer, Stefan Przyborski, of Reinnervate Ltd

26-Jul-2012 - Prof Stefan Przyborski, CSO and founder of Reinnervate Ltd, has been recognised with a top award from the Royal Society of Chemistry. The Rita and John Cornforth award 2012 recognises Prof. Przyborski’s leadership and inter-disciplinary work at the boundaries of physical chemistry and biology, ...

cell culture technology cell cultures cell culturing

Reinnervate Ltd and Roslin Cellab collaborate on the development of protocols for three dimensional growth of hESCs

30-Apr-2012 - Reinnervate Ltd and Roslin Cellab announced that they will join forces to develop protocols for the three dimensional growth of human Embryonic Stem Cells (hESCs).Prof Stefan Przyborski, CSO and founder of Reinnervate Ltd, commented: ‘It is well known that the physical environment in which cells ...

cell culturing human embryonic stem cells

Reinnervate expands its distribution network for alvetex across Europe

17-Oct-2011 - Reinnervate announced it has signed agreements with seven new European distributors for the non-exclusive distribution of alvetex®, its 3D cell culture technology.These agreements mark a significant expansion of reinnervate’s distribution network. Under the terms of the new agreements, alvetex® ...

cell culturing

Reinnervate completes expansion into new purpose-built facility at NETPark

18-Nov-2010 - Reinnervate announced its expansion into a new purpose-built research and production facility at NETPark near Sedgefield, UK. The move to the circa 10,000 square foot facility has enabled reinnervate to begin commercial production of its alvetex® 3D cell culture technology in readiness for its ...

cell culture technology cell cultures laboratories